Seeheim-Jugenheim, Germany

Kai Schiemann

USPTO Granted Patents = 55 

 

 

Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 276(Granted Patents)

Forward Citations (Not Self Cited) = 269(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Darmstadt, DE (2006 - 2010)
  • Seeheim-Jungenheim, DE (2011)
  • Seeheim-Jugenheim, DE (2007 - 2023)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
55 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Kai Schiemann

Introduction

Kai Schiemann is an esteemed inventor based in Seeheim-Jugenheim, Germany. With a prolific portfolio of 54 patents, he has made significant advancements in the fields of biochemistry and pharmaceuticals. His inventions contribute to potential therapies for various diseases, showcasing his dedication to scientific innovation.

Latest Patents

Among his latest patents are innovative compounds such as imidazolonylquinolines, which serve as ATM kinase inhibitors. These compounds illustrate promise in the treatment of cancer, revealing the potential for groundbreaking therapies in oncology. Another recent invention concerns benzimidazole derivatives, which act as adenosine receptor antagonists. These compounds are aimed at treating and preventing hyperproliferative or infectious diseases in mammals, particularly humans, and are included in pharmaceutical compositions.

Career Highlights

Throughout his career, Kai Schiemann has held positions with notable companies like Merck Patent GmbH and Cancer Research Technology Limited. His expertise in patent law and innovation has enabled him to navigate the complex landscape of pharmaceutical development while securing intellectual property rights for his inventions.

Collaborations

Schiemann has collaborated with prominent colleagues, including Wolfgang Staehle and Melanie Schultz. These partnerships have fostered a dynamic environment for research and development, leading to significant breakthroughs in medicinal chemistry and therapeutic interventions.

Conclusion

Kai Schiemann's contributions to the scientific community exemplify the impact of innovative thinking in healthcare. With a remarkable number of patents, his work continues to influence future research and treatment options across various medical disciplines. His dedication to enhancing human health through innovation underscores the importance of intellectual property in fostering scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…